Loading
Latest filing published 17 Feb 2026 for Envoy Medical, Inc., €337k. Read the official filing
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Charles Brynelsen on record concern Envoy Medical, Inc. Over a trading history stretching from 22 May 2025 to 12 February 2026, the count stands at 4 filings.
No open-market sale appears; the market trades are 4 purchases worth €410k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2026 to date brings 1 purchase and no sales.
Half of the purchases are above €35k and half below. On 1 out of 4 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 4 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -26.2%. These figures describe past trades and do not predict future prices.
On 17 February 2026 came the latest disclosure, an open-market purchase for €337k in Envoy Medical, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations